ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

Genetic Test Identifies Patients With High Risk of Mortality

November 30, 2012

Varmus: NCI Needs To Rethink, Review; Programs Must Be “At A High Level”

November 12, 2010

Emory Executive Objects to Report On Merit review

July 22, 1977

Massive Opposition Building To OMB Cuts; Legislative, Court Actions Predicted

February 22, 1985

B.J. Kennedy Receives ACCC Award, Says More Medical Oncologists Are Still Needed

April 5, 1985